WORLD DIAGNOSTICS INC
8-K, 2000-11-20
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: DELTA CAPITAL TECHNOLOGIES INC, 10QSB, EX-27.1, 2000-11-20
Next: WORLD DIAGNOSTICS INC, 8-K, EX-4, 2000-11-20



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                         Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

                                October 26, 2000
                                ----------------
                                 Date of Report
                        (Date of earliest event reported)

                             WORLD DIAGNOSTICS INC.
                             ----------------------
             (Exact name of registrant as specified in its charter)

       Delaware                   000-27627                65-0742342
------------------------   -----------------------   -----------------------
(State or other            (Commission               (IRS Employer
jurisdiction of            File Number)              Identification No.)
incorporation)

               15271 N.W. 60th AVENUE, MIAMI LAKES, FLORIDA 33014
               --------------------------------------------------
              (Address of registrant's principal executive offices)

                                 (305) 827-3304
                                 --------------
              (Registrant's telephone number, including area code)

<PAGE>
Items 5. World Diagnostics Inc. - $1,700,000 Private Equity Placement.

On October 26, 2000 World Diagnostics Inc. (the "Company") commenced closure of
a private placement of $1,700,000, consisting of 34 Units priced and $50,000 per
Unit, each consisting of (i) 50,000 shares of the Company's Common Stock, (ii)
50,000 "A" Warrants to purchase Common Stock at $1.375 per share, and (iii)
50,000 "B" Warrants to purchase Common Stock at $1.625 per share. The $1,700,000
private placement was completely funded on November 14, 2000. Under the
subscription documents, the Company is required to file a registration statement
for the Common Stock, the A Warrants and the B Warrants within 30 days of the
closing of the offering. The A Warrants and the B Warrants are generally
exercisable for five years, provided, however, that the A Warrants are
redeemable by the Company, at $0.10 per Warrant, under certain circumstances if
not otherwise exercised by the warrant holders.

     Exhibits.

      4.0   Subscription Agreement with Registration and Other Protective Rights

      4.1   Form of A Warrant to Purchase Common Shares

      4.2   Form of B Warrant to Purchase Common Shares

                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                     WORLD DIAGNOSTICS INC.

                                                     By: /s/ Ken Peters
                                                         --------------
                                                         Ken Peters
                                                         President

Date: November 20, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission